David G. Ginzinger

8.0k total citations · 3 hit papers
65 papers, 6.5k citations indexed

About

David G. Ginzinger is a scholar working on Molecular Biology, Genetics and Cancer Research. According to data from OpenAlex, David G. Ginzinger has authored 65 papers receiving a total of 6.5k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Molecular Biology, 22 papers in Genetics and 17 papers in Cancer Research. Recurrent topics in David G. Ginzinger's work include Lipid metabolism and disorders (8 papers), Genomics and Chromatin Dynamics (8 papers) and Genomic variations and chromosomal abnormalities (8 papers). David G. Ginzinger is often cited by papers focused on Lipid metabolism and disorders (8 papers), Genomics and Chromatin Dynamics (8 papers) and Genomic variations and chromosomal abnormalities (8 papers). David G. Ginzinger collaborates with scholars based in United States, Canada and Japan. David G. Ginzinger's co-authors include Bernhard H. F. Weber, John M. Gosline, Paul A. Guerette, Mamie Yu, Dan H. Moore, Chris Haqq, John Hodgson, Vita Fedele, Christopher C. Benz and Michael Mattie and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

David G. Ginzinger

63 papers receiving 6.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Gene quantification using real-time quantitative PCR

2002 1.0k citations David G. Ginzinger profile →
miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells

2008 781 citations Mamie Yu, David G. Ginzinger et al. profile →
Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies.

2006 589 citations Michael Mattie, Christopher C. Benz et al. Molecular Cancer profile →

Peers

Countries citing papers authored by David G. Ginzinger

Since Specialization

Citations

This map shows the geographic impact of David G. Ginzinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David G. Ginzinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David G. Ginzinger more than expected).

Fields of papers citing papers by David G. Ginzinger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David G. Ginzinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David G. Ginzinger. The network helps show where David G. Ginzinger may publish in the future.

Co-authorship network of co-authors of David G. Ginzinger

This figure shows the co-authorship network connecting the top 25 collaborators of David G. Ginzinger. A scholar is included among the top collaborators of David G. Ginzinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David G. Ginzinger. David G. Ginzinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Amplification of PVT1 Contributes to the Pathophysiology of Ovarian and Breast Cancer 2007 ·Clinical Cancer Research ·Yinghui Guan, Wen-Lin Kuo, Jackie L. Stilwell, Hirokuni Takano, Anna Lapuk, Jane Fridlyand, Jian‐Hua Mao, Mamie Yu, Melinda A. Miller, Jennifer L. Santos, Steve E. Kalloger, Joseph W. Carlson, David G. Ginzinger, S Celniker, Gordon B. Mills, David G. Huntsman, Joe W. Gray	295
2	Adrenocorticotropin Preferentially Up-Regulates Angiopoietin 2 in the Human Fetal Adrenal Gland: Implications for Coordinated Adrenal Organ Growth and Angiogenesis 2006 ·The Journal of Clinical Endocrinology & Metabolism ·Hitoshi Ishimoto, David G. Ginzinger, Robert B. Jaffe	24
3	Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies. breakdown → 2006 ·Molecular Cancer ·Michael Mattie, Christopher C. Benz, Jessica Bowers, (unknown), Linda Wong, Gary K. Scott, Vita Fedele, David G. Ginzinger, Robert Getts, Chris Haqq	589
4	Array-based comparative genomic hybridization reveals recurrent chromosomal aberrations and Jab1 as a potential target for 8q gain in hepatocellular carcinoma 2005 ·Carcinogenesis ·Mohini A. Patil, Ines Gütgemann, Ji Zhang, Coral Ho, ST Cheung, David G. Ginzinger, Rui Li, Karl Dykema, Samuel So, (unknown), Sanjay Kakar, Kyle A. Furge, Reinhard Büttner, Xin Chen	111
5	Copy Number Aberrations in Mouse Breast Tumors Reveal Loci and Genes Important in Tumorigenic Receptor Tyrosine Kinase Signaling 2005 ·Cancer Research ·John Hodgson, (unknown), Sophia Bornstein, Sujatmi Hariono, David G. Ginzinger, William J. Muller, Joe W. Gray	42
6	The ATM gene is a target for epigenetic silencing in locally advanced breast cancer 2004 ·Oncogene ·Quynh N. Vo, Wan-Ju Kim, (unknown), Donald A. Boudreau, David G. Ginzinger, Kevin D. Brown	87
7	Id1 Gene Expression Is Up-Regulated in Hyperplastic and Neoplastic Thyroid Tissue and Regulates Growth and Differentiation in Thyroid Cancer Cells 2004 ·The Journal of Clinical Endocrinology & Metabolism ·Electron Kebebew, Miao Peng, Patrick Treseler, Orlo H. Clark, Quan‐Yang Duh, David G. Ginzinger, Richard C. Miner	28
8	Nrf1 Is Critical for Redox Balance and Survival of Liver Cells during Development 2003 ·Molecular and Cellular Biology ·Lingyun Chen, Mandy Kwong, Ronghua Lu, David G. Ginzinger, (unknown), Laura Leung, Jefferson Y. Chan	117
9	CMRF-35-Like Molecule-1, a Novel Mouse Myeloid Receptor, Can Inhibit Osteoclast Formation 2003 ·The Journal of Immunology ·(unknown), Mary Beth Humphrey, Mary C. Nakamura, David G. Ginzinger, William E. Seaman, Michael R. Daws	97
10	Diagnostic and Prognostic Value of Fas and Telomeric-Repeat Binding Factor-1 Genes in Adrenal Tumors 2003 ·The Journal of Clinical Endocrinology & Metabolism ·Hajime Kanauchi, Nobuyuki Wada, David G. Ginzinger, Mamie Yu, Mariwil G. Wong, Orlo H. Clark, Quan‐Yang Duh	11
11	Skeletal unloading induces resistance to insulin-like growth factor I on bone formation 2003 ·Bone ·Takeshi Sakata, Bernard P. Halloran, Hashem Elalieh, Scott Munson, (unknown), (unknown), David G. Ginzinger, Clifford J. Rosen, Daniel D. Bikle	64
12	Quantitative analysis of cathepsin L mRNA and protein expression during oral cancer progression 2003 ·Oral Oncology ·(unknown), Caroline H. Shiboski, Sol Silverman, David G. Ginzinger, Nusi P. Dekker, David T. Wong, Richard C. Jordan	37
13	Quantitation of Membrane Type Serine Protease 1 (MT-SP1) in Transformed and Normal Cells 2003 ·Biological Chemistry ·Ami S. Bhatt, Tamotsu Takeuchi, Bauke Ylstra, David G. Ginzinger, Donna G. Albertson, Marc A. Shuman, Charles S. Craik	26
14	Measurements of Human Papillomavirus Transcripts by Real Time Quantitative Reverse Transcription-Polymerase Chain Reaction in Samples Collected for Cervical Cancer Screening 2002 ·Journal of Molecular Diagnostics ·(unknown), James Deeds, David G. Ginzinger, Jean Perry, (unknown), Karen Smith‐McCune	30
15	Insulin‐Like Growth Factor I Is Required for the Anabolic Actions of Parathyroid Hormone on Mouse Bone 2002 ·Journal of Bone and Mineral Research ·Daniel D. Bikle, Takeshi Sakata, (unknown), Hashem Elalieh, David G. Ginzinger, Clifford J. Rosen, Wesley G. Beamer, Sharmila Majumdar, Bernard P. Halloran	195
16	Induction of hypervascularity without leakage or inflammation in transgenic mice overexpressing hypoxia-inducible factor-1α 2001 ·Genes & Development ·(unknown), Gavin Thurston, Eric Huang, David G. Ginzinger, Donald M. McDonald, Randall S. Johnson, Jeffrey M. Arbeit	251
17	Comprehensive Genome Sequence Analysis of a Breast Cancer Amplicon 2001 ·Genome Research ·Colin C. Collins, Stanislav Volik, David Kowbel, David G. Ginzinger, Bauke Ylstra, (unknown), Trevor Hawkins, Paul Predki, Christopher Martin, Meredith Wernick, Wen-Lin Kuo, Arthur S. Alberts, Joe W. Gray	30
18	Diet-induced atherosclerosis in the domestic cat. 1997 ·PubMed ·David G. Ginzinger	15
19	Gene-environment interaction in the conversion of a mild-to-severe phenotype in a patient homozygous for a Ser172-->Cys mutation in the lipoprotein lipase gene. 1993 ·Journal of Clinical Investigation ·Yuxuan Ma, (unknown), David G. Ginzinger, J. Frohlich, John D. Brunzell, Michael R. Hayden	55
20	The human loci DNF15S2 and D3S94 have a high degree of sequence similarity to acyl-peptide hydrolase and are located at 3p21.3. 1992 ·PubMed ·David G. Ginzinger, Viji Shridhar, Antonio Baldini, R.T. Taggart, O. J. Miller, Jeremy C. Smith	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact